Cargando…

Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment

Compared with the extensive data on left‐sided infective endocarditis (IE), there is much less published information on the features and management of right‐sided IE. Right‐sided IE accounts for 5% to 10% of all IE cases, and compared with left‐sided IE, it is more often associated with intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Shmueli, Hezzy, Thomas, Felix, Flint, Nir, Setia, Gayatri, Janjic, Aleksandar, Siegel, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792231/
https://www.ncbi.nlm.nih.gov/pubmed/32700630
http://dx.doi.org/10.1161/JAHA.120.017293
_version_ 1783633759343476736
author Shmueli, Hezzy
Thomas, Felix
Flint, Nir
Setia, Gayatri
Janjic, Aleksandar
Siegel, Robert J.
author_facet Shmueli, Hezzy
Thomas, Felix
Flint, Nir
Setia, Gayatri
Janjic, Aleksandar
Siegel, Robert J.
author_sort Shmueli, Hezzy
collection PubMed
description Compared with the extensive data on left‐sided infective endocarditis (IE), there is much less published information on the features and management of right‐sided IE. Right‐sided IE accounts for 5% to 10% of all IE cases, and compared with left‐sided IE, it is more often associated with intravenous drug use, intracardiac devices, and central venous catheters, all of which has become more prevalent over the past 20 years. In this manuscript on right‐sided IE we provide an up‐to‐date overview on the epidemiology, etiology, microbiology, potential locations of infection in the right heart, diagnosis, imaging, common complications, management, and prognosis. We present updated information on the treatment of pacemaker and device infections, infected fibrin sheaths that appear to be an easily missed source of infection after central line as well as pacemaker removal. We review current data on the AngioVac percutaneous aspiration device, which can obviate the need for surgery in patients with infected pacemaker leads and fibrin sheaths. We also focused on advanced diagnostic modalities, such as positron emission tomography/computed tomography. All of these are supported by specific case examples with detailed echocardiographic imaging from our experience.
format Online
Article
Text
id pubmed-7792231
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77922312021-01-15 Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment Shmueli, Hezzy Thomas, Felix Flint, Nir Setia, Gayatri Janjic, Aleksandar Siegel, Robert J. J Am Heart Assoc Contemporary Reviews Compared with the extensive data on left‐sided infective endocarditis (IE), there is much less published information on the features and management of right‐sided IE. Right‐sided IE accounts for 5% to 10% of all IE cases, and compared with left‐sided IE, it is more often associated with intravenous drug use, intracardiac devices, and central venous catheters, all of which has become more prevalent over the past 20 years. In this manuscript on right‐sided IE we provide an up‐to‐date overview on the epidemiology, etiology, microbiology, potential locations of infection in the right heart, diagnosis, imaging, common complications, management, and prognosis. We present updated information on the treatment of pacemaker and device infections, infected fibrin sheaths that appear to be an easily missed source of infection after central line as well as pacemaker removal. We review current data on the AngioVac percutaneous aspiration device, which can obviate the need for surgery in patients with infected pacemaker leads and fibrin sheaths. We also focused on advanced diagnostic modalities, such as positron emission tomography/computed tomography. All of these are supported by specific case examples with detailed echocardiographic imaging from our experience. John Wiley and Sons Inc. 2020-07-23 /pmc/articles/PMC7792231/ /pubmed/32700630 http://dx.doi.org/10.1161/JAHA.120.017293 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Contemporary Reviews
Shmueli, Hezzy
Thomas, Felix
Flint, Nir
Setia, Gayatri
Janjic, Aleksandar
Siegel, Robert J.
Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment
title Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment
title_full Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment
title_fullStr Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment
title_full_unstemmed Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment
title_short Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment
title_sort right‐sided infective endocarditis 2020: challenges and updates in diagnosis and treatment
topic Contemporary Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792231/
https://www.ncbi.nlm.nih.gov/pubmed/32700630
http://dx.doi.org/10.1161/JAHA.120.017293
work_keys_str_mv AT shmuelihezzy rightsidedinfectiveendocarditis2020challengesandupdatesindiagnosisandtreatment
AT thomasfelix rightsidedinfectiveendocarditis2020challengesandupdatesindiagnosisandtreatment
AT flintnir rightsidedinfectiveendocarditis2020challengesandupdatesindiagnosisandtreatment
AT setiagayatri rightsidedinfectiveendocarditis2020challengesandupdatesindiagnosisandtreatment
AT janjicaleksandar rightsidedinfectiveendocarditis2020challengesandupdatesindiagnosisandtreatment
AT siegelrobertj rightsidedinfectiveendocarditis2020challengesandupdatesindiagnosisandtreatment